Business Standard

Syncom Formulations (India) standalone net profit rises 27.17% in the March 2019 quarter

Image

Capital Market

Sales rise 56.11% to Rs 61.24 crore

Net profit of Syncom Formulations (India) rose 27.17% to Rs 2.20 crore in the quarter ended March 2019 as against Rs 1.73 crore during the previous quarter ended March 2018. Sales rose 56.11% to Rs 61.24 crore in the quarter ended March 2019 as against Rs 39.23 crore during the previous quarter ended March 2018.

For the full year,net profit rose 28.21% to Rs 11.09 crore in the year ended March 2019 as against Rs 8.65 crore during the previous year ended March 2018. Sales rose 17.74% to Rs 186.77 crore in the year ended March 2019 as against Rs 158.63 crore during the previous year ended March 2018.

 
ParticularsQuarter EndedYear EndedMar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.Sales61.2439.23 56 186.77158.63 18 OPM %4.675.28 -6.327.36 - PBDT4.163.41 22 16.6715.85 5 PBT3.152.38 32 12.6712.12 5 NP2.201.73 27 11.098.65 28

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 05 2019 | 5:47 PM IST

Explore News